Celtaxsys, Inc.: Clinical Trials

6 trials sponsored by Celtaxsys, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 22Completed 2

Follow Celtaxsys, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-Acebilustat (CTX-4430)
[14C]-acebilustat solution - Heathy Volunteers
Phase 1CompletedCeltaxsys, Inc.62019-04-012019-05-30
EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients
CTX-4430, Placebo - Cystic Fibrosis
Phase 2CompletedCeltaxsys, Inc.2002015-10-302019-09-04
CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris
CTX-4430, Placebo - Acne Vulgaris
Phase 2CompletedCeltaxsys, Inc.1242015-04-012016-08-02
Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam
CTX-4430, Midazolam - Healthy
Phase 1CompletedCeltaxsys, Inc.202014-09-012014-10-10
Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients
CTX-4430, Placebo - Cystic Fibrosis
Phase 1CompletedCeltaxsys, Inc.172013-09-012015-03-06
Phase 1 Study Assessing the Safety and Tolerability of CTX-4430
CTX-4430, Mannitol, Placebo - Pulmonary Inflammation
Phase 1CompletedCeltaxsys, Inc.962012-12-012013-09-10

Conditions studied

Cystic Fibrosis (2)  ·  Acne Vulgaris (1)  ·  Pneumonia (1)

Interventions

acebilustat (5)  ·  Mannitol (2)  ·  Midazolam (1)

Countries

United Kingdom (4)  ·  Australia (2)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  New Zealand (1)  ·  United States (1)

Top investigators

J Stuart Elborn, MD, FRCP (1)  ·  Janakan Krishnarajah, MB, BS FRACP (1)  ·  Johnston Stewart, MB, BSc (1)  ·  Lynda J Spelman, MB BS, FACD (1)  ·  Steven Rowe, MD (1)  ·  Stuart Elborn, MD (1)